Annmargret Håkansson

Title: Inventor Annmargret Håkansson: Innovating Renal Replacement Therapy

Introduction

Annmargret Håkansson, an accomplished inventor based in Kagerod, Sweden, has made significant contributions to the field of medical technology. With a total of two patents to his name, Håkansson is recognized for his innovative solutions in renal replacement therapy, showcasing his expertise in enhancing patient care and treatment methodologies.

Latest Patents

Håkansson's latest patents include a "System and a method for renal replacement therapy" and "Systems and methods including a human-shaped graphical element." The renal replacement therapy system comprises a blood treatment unit connected to both a blood circuit and a dialysis fluid circuit. This advanced system features a control unit programmed to manage treatment according to specific control instructions, enabling it to assess system parameters and detect membrane fouling. An intelligent automatic anti-fouling measure is incorporated, which temporarily alters blood flow rates and reduces ultrafiltration rates, all synchronized for optimal effectiveness.

The second patent focuses on graphical user interfaces for extracorporeal blood treatment systems. This innovation includes human-shaped graphical elements that provide intuitive interactions for users, allowing them to navigate process features effectively. Such graphical interfaces enhance usability and improve the overall experience for medical professionals.

Career Highlights

Håkansson is currently employed at Gambro Lundia AB, a company renowned for its focus on renal therapy innovations. His role involves collaborating with cutting-edge technology and contributing to advancements in healthcare solutions. Håkansson's work is integral to the development of technologies that improve the quality of life for patients undergoing renal treatments.

Collaborations

Throughout his career, Håkansson has worked alongside esteemed colleagues, including Roger Nilsson and Par-Olof Håkansson. This collaborative environment fosters innovation and enables the sharing of diverse ideas, which is essential in the rapidly evolving field of medical technology.

Conclusion

In summary, Annmargret Håkansson stands out as a prominent inventor in the medical technology sector, particularly in renal replacement therapy. With his innovative patents and collaborative efforts at Gambro Lundia AB, Håkansson continues to push the boundaries of what is possible in patient care. His contributions not only reflect his dedication to medical advancements but also highlight the importance of innovation in enhancing healthcare outcomes.